Director/PDMR Shareholding

RNS Number : 1173G

Dechra Pharmaceuticals PLC

27 February 2018

 

27 February 2018

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

Dechra Pharmaceuticals PLC has been notified that on 26 February 2018 Lawson Macartney, Non-Executive Director, purchased 2,940 American Depositary Receipts (ADRs) in the Company at a price of US$68 each. This is equivalent to 5,880 ordinary shares in the Company.

Following this acquisition, Lawson Macartney's beneficial interest in the Company is 5,880 shares (0.006% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Lawson Macartney
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	American Depositary Receipts (ADRs) in Dechra Pharmaceuticals PLC (each ADR represents 2 ordinary shares DPHAY/CUSIP: 243435-10-4
b)	Nature of the transaction	Purchase of ADRs
c)	Price(s) and volumes(s)	Price(s) $68	2,940
d)	Aggregated information -   Aggregate volume -   Price -   Total	2,940 $68 $199,920
e)	Date of the transaction	2018-02-27
f)	Place of the transaction	United States

For further information, please contact:

Melanie Hall, Company Secretary             

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHFKODDQBKDPBB